Manufacturing and use of human placenta-derived mesenchymal stromal cells for phase I clinical trials: Establishment and evaluation of a protocol by Ilić Nina, Atkinson Kerry

Get full text

PIK3CA mutant tumors depend on oxoglutarate dehydrogenase by Ilic, Nina, Birsoy, Kıvanç, Aguirre, Andrew J., Singh, Shambhavi, Moody, Susan E., DeAngelo, Joseph D., Spardy, Nicole A., Freinkman, Elizaveta, Weir, Barbara A., Tsherniak, Aviad, Cowley, Glenn S., Root, David E., Asara, John M., Vazquez, Francisca, Widlund, Hans R., Hahn, William C., Kory, Nora, Sabatini, David, Pacold, Michael Edward

Get full text
Get full text
Get full text

KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer by Krall, Elsa B, Munoz, Diana M, Ilic, Nina, Niederst, Matthew J, Yu, Kristine, Ruddy, David A, Redig, Amanda J, Gainor, Justin F, Williams, Juliet A, Asara, John M, Janne, Pasi A, Shaw, Alice T, McDonald III, Robert E, Engelman, Jeffrey A, Stegmeier, Frank, Schlabach, Michael R, Wang, Belinda, Raghavan, Srivatsan, Aguirre, Andrew J., Kim, Jong Wook, Doench, John Gerard, Hahn, William

Get full text
Get full text